Erdheim-Chester disease: consensus recommendations for evaluation, diagnosis, and treatment in the molecular era

G Goyal, ML Heaney, M Collin… - Blood, The Journal …, 2020 - ashpublications.org
Erdheim-Chester disease (ECD) is a rare histiocytosis that was recently recognized as a
neoplastic disorder owing to the discovery of recurrent activating MAPK (RAS-RAF-MEK …

Rosai-Dorfman disease: an overview

C Bruce-Brand, JW Schneider… - Journal of clinical …, 2020 - jcp.bmj.com
Context Rosai-Dorfman disease is an uncommon histiocytic disorder most frequently
presenting as bilateral cervical lymphadenopathy in children and young adults. Extranodal …

Histiocytosis

JF Emile, F Cohen-Aubart, M Collin, S Fraitag, A Idbaih… - The Lancet, 2021 - thelancet.com
Histiocytoses constitute a heterogeneous group of rare disorders, characterised by
infiltration of almost any organ by myeloid cells with diverse macrophage or dendritic cell …

Histiocytic neoplasms, version 2.2021, NCCN clinical practice guidelines in oncology

RS Go, E Jacobsen, R Baiocchi, I Buhtoiarov… - Journal of the National …, 2021 - jnccn.org
Histiocytic neoplasms are rare hematologic disorders accounting for less than 1% of cancers
of the soft tissue and lymph nodes. Clinical presentation and prognosis of these disorders …

Imaging in Erdheim-Chester Disease

Y Aswani, A Patel, X Zhan, S Ansari, LG Marcelino… - Radiographics, 2024 - pubs.rsna.org
Erdheim-Chester disease (ECD) is a rare, multisystemic, inflammatory, non–Langerhans cell
histiocytic neoplasm. The discovery of recurrent and somatic mutations in the mitogen …

The Mayo Clinic Histiocytosis Working Group consensus statement for the diagnosis and evaluation of adult patients with histiocytic neoplasms: Erdheim-Chester …

G Goyal, JR Young, MJ Koster, WO Tobin… - Mayo Clinic …, 2019 - Elsevier
Histiocytic neoplasms, a rare and heterogeneous group of disorders, primarily include
Erdheim-Chester disease, Langerhans cell histiocytosis, and Rosai-Dorfman disease. Due …

Rosai-Dorfman disease displays a unique monocyte-macrophage phenotype characterized by expression of OCT2

A Ravindran, G Goyal, RS Go… - The American Journal of …, 2021 - journals.lww.com
Rosai-Dorfman disease (RDD) is a rare histiocytosis with heterogenous clinical features. In
this study, we characterized the histologic and phenotypic features in 33 RDD patients to …

Histiocytosis and the nervous system: from diagnosis to targeted therapies

F Cohen Aubart, A Idbaih, JF Emile, Z Amoura… - Neuro …, 2021 - academic.oup.com
Histiocytoses are heterogeneous hematopoietic diseases characterized by the accumulation
of CD68 (+) cells with various admixed inflammatory infiltrates. The identification of the …

Rosai–Dorfman disease between proliferation and neoplasia

I Elbaz Younes, L Sokol, L Zhang - Cancers, 2022 - mdpi.com
Simple Summary Rosai–Dorfman disease (RDD) was a benign histiocytic proliferative
disorder rather than a neoplastic process. Emergent molecular studies have shown …

Erdheim-chester disease

J Haroche, F Cohen-Aubart… - Blood, The Journal of the …, 2020 - ashpublications.org
Erdheim-Chester disease (ECD) is characterized by the infiltration of tissues by foamy
CD68+ CD1a− histiocytes, with 1500 known cases since 1930. Mutations activating the …